Almotriptan Tablet, Film Coated
Product Images NDC 27241-042

6 FDA label images from Ajanta Pharma Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Almotriptan (NDC 27241-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Almotriptan Str)

Structure (Almotriptan Str)
Chemical structure of almotriptan. The diagram shows the molecular arrangement including a sulfonamide group, an indole moiety, and an acidic component indicating the presence of a salt form.*
FDA Label Image

Figure_01 (Figure 01)

Figure_01 (Figure 01)
A line graph depicting the probability of a measured outcome over hours post dose (0 to 2 hours) for almotriptan tablets at 6.25 mg and 12.5 mg doses compared to placebo. The x-axis shows hours post dose, and the y-axis shows the probability, ranging from 0 to 1. Almotriptan 12.5 mg shows the highest probability increase, followed by 6.25 mg, with placebo showing the lowest.*
FDA Label Image

Figure_02 (Figure 02)

Figure_02 (Figure 02)
A line graph displaying probability over time (hours post dose) for three treatment groups: placebo, almotriptan 6.25 mg tablets, and almotriptan 12.5 mg tablets. The x-axis represents hours post dose up to 24 hours, and the y-axis represents probability ranging from 0 to 1. The chart compares the response probabilities for the different doses and placebo over a 24-hour period.*
FDA Label Image

Figure_03 (Figure 03)

Figure_03 (Figure 03)
A line graph showing the estimated probability of response over hours post dose for placebo and almotriptan tablets at 6.25 mg and 12.5 mg strengths. The x-axis represents hours post dose (0 to 2), and the y-axis represents estimated probability of response (0 to 1). Both almotriptan doses show higher probability of response compared to placebo over time.*
FDA Label Image

6.25mg (Almotriptan 6 25 mg)

6.25mg (Almotriptan 6 25 mg)
Packaging label for Almotriptan 6.25 mg film-coated tablets, USP, oral dosage form. The label shows the product name, strength, and dosage form clearly, along with storage instructions and manufacturer information. It states the product is manufactured by Ajanta Pharma Limited, India, and marketed by Ajanta Pharma USA Inc.*
FDA Label Image

12.5mg (Almotriptan 12 5 mg)

12.5mg (Almotriptan 12 5 mg)
Packaging label for Almotriptan Tablets USP 12.5 mg film-coated tablets by Ajanta Pharma USA Inc. The carton indicates an oral dosage form with 12 tablets (2x6 unit dose). It includes storage information, manufacturer details (Ajanta Pharma Limited, India), and a barcode. The label displays the product name and strength prominently in red text on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.